Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
A bio-what? Medical companions’ perceptions towards biosimilars and information needs in rheumatology
Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
Overview of Biosimilars for Immune-Mediated Inflammatory Diseases: Summary of Current Evidence
Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study
OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis
Biosimilars (National Psoriasis Foundation)
Position Statement on the Use of Biosimilars for Psoriasis and Psoriatic Arthritis
